Latest Ketones Stories
CAMBRIDGE, England, October 7, 2014 /PRNewswire/ -- Acacia Pharma announces positive Phase 3 results with APD421 for the management of post-operative nausea & vomiting
The Firm is evaluating Xarelto lawsuits on behalf of individuals who suffered life-threatening internal bleeding, deep vein thrombosis, pulmonary embolism, and other serious complications, allegedly
Conference Call Scheduled for Tuesday, October 7 at 8:00 AM Eastern Time RALEIGH, N.C., Oct. 6, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc.
New white paper released as hydrocodone is reclassified as a Schedule II drug ITASCA, Ill., Oct.
LONDON, Oct. 2, 2014 /PRNewswire/ -- Lightlake Therapeutics Inc.
According to a new position statement from the American Academy of Neurology, the risk of death, overdose, addiction or serious side effects with prescription opioids outweigh the benefits in chronic, non-cancer conditions such as headache, fibromyalgia and chronic low back pain.
JOHNSTOWN, Pa., Sept.
ST. PAUL, Minn., Sept. 30, 2014 /PRNewswire/ -- In 2011, approximately 5.1 million people in the United States abused prescription pain relievers (e.g.
KemPharm's Intellectual Property Estate Now Includes Composition of Matter Patents for Two Ligand Activated Technology (LAT) Opioid Prodrugs - KP511 and KP201 CORALVILLE, Iowa, Sept.
PAINWeekEnd Denver will be convened on Saturday, October 4, at the Denver Marriott City Center at 1701 California Street. Montclair, NJ (PRWEB) September 28,
- The governor of a province or people.
More Images (1 images) »